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Abstract A novel potential regulatory pathway of brown 
adipose tissue (BAT) thermogenesis was recently recognized 
after identifying retinoic acid (RA) as a transcriptional activator 
of the uncoupling protein (UCP) gene. Here we provide evidence 
that the UCP responsiveness to RA in primary cultures of brown 
adipocytes involves RA receptor a (RARa), and show, in the 
same system and also in CHO cells, that RA down-regulates the 
steady-state levels of RARa and especially of retinoid X receptor 
a, suggesting autoregulation of the retinoid pathway and 
therefore supporting the idea of a physiological role for it in 
controlling the thermogenic capacity of BAT. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The uncoupling protein (UCP) or thermogenin is an inner 
mitochondrial membrane protein characteristically expressed 
in mammalian brown adipocytes that functions as a proton 
channel, thus uncoupling the activity of the respiratory chain 
from ATP synthesis [1,2]. It constitutes the molecular machi-
nery for brown adipose tissue (BAT) thermogenesis, which is 
activated in response to cold exposure or to excessive caloric 
intake [3]. Norepinephrine, acting via cAMP, appears as the 
main regulator of UCP synthesis and activity [4,5], as well as 
of BAT recruitment [6]. Recently, however, a novel potential 
regulatory pathway of brown fat thermogenesis was recog-
nized involving the natural vitamin A derivative retinoic 
acid (RA). It was shown that RA stimulates UCP mRNA 
accumulation in immortalized brown adipocytes [7] and in 
primary cultures of brown adipocytes [8], as well as the ap-
pearance of mature UCP not only in in vitro cell culture 
systems but also in BAT of whole mice [9], thus suggesting 
a physiological role of RA in regulating the thermogenic ca-
pacity of BAT. The nucleotide sequence conferring RA re-
sponsiveness to the UCP gene has been recently identified 
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and characterized as a novel complex RA response element 
[10,11]. 
Cellular responses to retinoids are generally mediated by 
two families of nuclear receptors that belong to the steroid-
thyroid hormone receptor superfamily and behave as ligand-
activated transcription factors that bind as dimers to the ex-
acting response elements of target genes (reviewed in [12]). 
The retinoic acid receptors (RARs) are activated by both 
ail-fraM.s-RA (tRA) and 9-cw-RA, whereas the retinoid X re-
ceptors (RXRs) only show binding affinity for 9-cu*-RA. So 
far, three main isotypes of RARs (a, [3 and y) and RXRs (a, [3 
and y) have been recognized in mammalian tissues. RAR/ 
RXR heterodimers appear to preferentially transduce the ret-
inoid signal in vivo [12]; RXRs also form heterodimers with a 
number of other hormone receptors, such as thyroid hormone 
receptor, vitamin D3 receptors, and peroxisome proliferator 
activated receptors [12]. 
As happens with most RA-responsive genes, RAR/RXR 
heterodimers seem to mediate the responsiveness of the 
UCP gene to RA. This was suggested by transfection experi-
ments showing that ectopic co-expression of both RARa and 
RXRa maximally enhanced the RA responsiveness of the rat 
UCP gene promoter when introduced into cells devoid of 
endogenous RXRa [8], and by electrophoretic mobility shift 
assay experiments showing that the RA-responsive sequence 
of the rat UCP gene is able to support the formation of 
heterodimers between different isotypes of RAR (a, P, and 
y) and RXRa, but not of homodimers of these receptors [10]. 
Here, we provide evidence that the UCP responsiveness to 
RA in primary cultures of brown adipocytes involves RARa, 
and show that RA modulates the steady-state levels of both 
RARa and RXRa. 
2. Materials and methods 
2.1. Materials 
(±)Arterenol bitartrate salt (noradrenaline) and tRA were from 
Sigma (Spain). RO 41-5253 was a generous gift of Roche S.A. (Spain). 
Rabbit polyclonal antisera against RARa (F region) and RXRa (A 
region) were provided by IGBMC (Illkirch, France). Newborn calf 
serum and Dulbecco's modified Eagle's medium (DMEM) were ob-
tained from ICN (Spain) and human insulin (Actrapid) from Novo 
Industries (Denmark). F12 medium and fetal bovine serum were from 
Gibco BRL (Paisley, UK). Other cell culture reagents were supplied 
by Sigma, and routine chemicals were from Sigma (Spain), Merck 
(Spain) and Panreac (Spain). 
2.2. Primary cell culture 
BAT precursor cells from 4-week-old mice were prepared, inocu-
lated and cultured as earlier described [13], in 6-well multidish plates. 
The culture medium consisted of DMEM supplemented with 10% 
newborn calf serum, 4 nM insulin, 10 mM HEPES and 126 mM 
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Fig. 1. Effect of RO 41-5253 on the tRA-induced appearance of UCP in cultured primary brown adipocytes. Cells were treated with a single 
dose of tRA 10~5 M alone or with the indicated concentrations of RO 41-5253, for a period of 48 h, from day 5 to day 7 of culture, before 
being harvested. The UCP content of cell lysates was quantified by densitometric scanning of immunoblots. Results are expressed relative to 
the specific UCP content of cells treated with tRA only (maximal value) and are the mean ± S.E.M of 4 experimental data. A representative im-
munoblot is shown (100 ug of cellular lysate protein were run per lane). Control (C), untreated culture. 
sodium ascorbate, and with 50 units of penicillin and 50 mg of strep-
tomycin per ml. Cells were grown at 37°C in an atmosphere of 8% 
CO2 in air. The culture medium was changed on the first and the third 
day after inoculation. The cells were treated with tRA, alone or in 
combination with different concentrations of RO 41-5253, at the times 
and doses indicated in the figure legends, after changing the culture 
medium. Cells were harvested at confluence (day 7); the culture me-
dium was removed and the cells rinsed twice with ice-cold phosphate-
buffered saline (PBS: 137 mM NaCl, 2.7 mM KC1 and 10 mM phos-
phate buffer, pH 7.4) and then scraped into 1.5 ml of PBS and trans-
ferred to an Eppendorf tube. The cell suspensions were pelleted, re-
suspended in a minimal volume of PBS containing PMSF (0.2 mM 
final concentration) and stored at —20°C prior to sonication and 
analysis. 
2.3. Cell lines, plasmids and transfections 
CHO Kl cells were grown on 100 mm diameter plates in F12 
medium supplemented with 10% fetal bovine serum, at 37°C and 
8% C0 2 . They were treated with a single dose of tRA of 10~
5 M 
dissolved in ethanol when 50-70% confluent, and further incubated 
for a period of 20 h before being harvested; control cells received 
ethanol only. Transient transfection of 50-70% confluent CHO Kl 
cells was by the CaP04 precipitation method [14], with 20 u.g of the 
expression plasmid pSV'sportlhRXRct [15], which contains an EcoRl 
fragment comprising the full translation reading frame of human 
RXRa cloned into the EcoRl site of pSV'sportl. One milliliter of 
CaP04 precipitate was added to each plate. After 4 h, the cells were 
shocked with glycerol, washed twice with PBS, refed with 8 ml of 
fresh medium supplemented or not with tRA 10~5 M, and further 
incubated for 20 h before harvesting. Harvesting and preparation of 
cell lysates were as described above. All experiments were performed 
in triplicate. 
2.4. Parameters determined 
Protein was determined by the method of Bradford [16]. UCP, 
RARa and RXRa were determined by immunoblotting. Proteins 
(70-100 |xg) from whole cell lysates were fractionated by SDS-
PAGE (10%o polyacrylamide) according to Laemmli [17] and electro-
transferred onto a nitrocellulose filter as described in [18]. For UCP 
determination, rabbit polyclonal antisera raised against purified rat 
UCP obtained in our laboratory [18] was used as primary antibody. 
Procedures for obtaining the UCP antiserum are described elsewhere 
[18]; its specificity for UCP (33 kDa) was confirmed by immunoblot-
ting of BAT homogenate proteins, liver homogenate proteins and 
purified UCP. RARa and RXRa were detected using rabbit polyclo-
nal antibodies raised against synthetic peptides corresponding to 
cDNA-deduced amino acid sequences of mouse RARal (F region) 
and RXRa (A region), respectively; these antibodies were previously 
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Fig. 2. Effect of tRA on the levels of RXRa, RARa and UCP of cultured primary brown adipocytes. A single dose of tRA (10~5-10~9 M) 
was added to the cultures on day 5. Cells were harvested on day 7 and the RXRa, RARa and UCP contents of cell lysates quantified by den-
sitometric scanning of the corresponding immunoblots. RXRa and RARa data are expressed relative to the corresponding levels in control cul-
tures not treated with tRA; UCP data are expressed relative to the maximal expression attained. The results are the mean±S.E.M. of 
6 (RXRa and RARa results) or 3 (UCP results) independent experiments. Immunoblots for RARa and RXRa: 50 ug of cellular lysate protein 
were run per lane; C, control untreated culture; +C, liver extract (70 u.g protein) that served as positive control. 
determined to be specific for various species of RARa (of ~ 58, ~ 54 
and ~ 51 kDa) and for a single species of RXRa (~ 54 kDa), re-
spectively, in different cell systems and tissues [19,20]. Further con-
firmation of the RXRa band was obtained by transfecting CHO cells 
with the corresponding gene cloned into an expression plasmid (see 
Section 2.3). Blocking and development of the immunoblots were 
performed using an ECL Western blotting analysis system (Amer-
sham), with horseradish peroxidase-coupled donkey anti-rabbit IgG 
as second antibody, and following the instructions of the manufac-
turer. The films used were Kodak X-Omat AR films. For quantitative 
analysis, films were scanned with a Biolmage computing densitometer 
(Millipore). 
3. Results and discussion 
To further define the RAR involved in the endogenous 
UCP responsiveness to RA, we evaluated in tRA-stimulated 
primary cultures of brown adipocytes the effect of the selective 
RARa antagonist RO 41-5253, which binds to RARa pre-
venting activation by RA [21]. As shown in Fig. 1, RO 41-
5253 inhibited the tRA-induced appearance of UCP in a dose-
dependent manner, strongly suggesting that in our system the 
effect of RA on UCP appearance occurs through RARa. In 
HIB cells - a mouse cell line derived from a brown fat hiber-
noma - RARy-RXRa heterodimers have been claimed to me-
diate UCP responsiveness to RA on the basis of supershift 
assay experiments showing that anti-RXRa and anti-RARy 
antibodies, but not anti-RARa or anti-RARfJ, are capable 
to supershift the RA-responsive sequence of the rat UCP 
gene retarded by nuclear extracts of these cells [10]; however, 
the authors did not exclude the possibility that other receptors 
also participate. Studies at the RNA level have revealed that, 
in the mouse, RARa is the most ubiquitously distributed 
RAR isotype, while RARp and RARy display a more re-
stricted pattern of distribution [12]. 
Transcription of some RAR genes themselves as well as of 
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Fig. 3. Time-course of the decrease of RARa and RXRa levels eli-
cited by tRA 10~5 M in cultured primary brown adipocytes. A sin-
gle dose of tRA 10-5 M was added to the cells on day 5. Control 
(untreated) and tRA-treated cells were harvested 3, 6, 12, 24 and 48 
h after addition of tRA. RXRa and RARa contents of cell lysates 
were quantified by densitometric scanning of immunoblots. Data 
are expressed relative to the total RARa or RXRa content of the 
corresponding time control cultures (100%), and are the mean± 
S.E.M. of 6 independent experiments. 
certain proteins involved in the storage, transport and/or me-
tabolism of retinol and RA have been shown to be RA-sensi-
tive [21-23]. Therefore, we investigated in our primary cell 
culture system the effect of tRA on the relative steady-state 
levels of RARa and RXRa, by means of immunoblotting 
(Fig. 2). The two receptors were present in cultured primary 
brown fat cells, consistent with their endogenous responsive-
ness to RA. RXRa appeared as a single band corresponding 
to a protein with an apparent molecular weight of ~ 54 kDa, 
in agreement with the predicted molecular weight of mouse 
RXRa and with previous reports making use of the same 
antibody preparation [20]; we further identified this band as 
RXRa by means of transfection experiments in which ectopic 
expression of RXRa was forced in CHO cells (see Fig. 4). In 
the case of RARa, the antibodies used were previously re-
ported to specifically detect at least three different RARa 
proteins species of ~ 5 8 , ~ 5 4 and ~ 5 1 kDa in mouse em-
bryos and various adult mouse tissues [19]; in our primary 
cultures, we always recognized the 58 kDa species and a 
slightly faster migrating band of about 54 kDa that displayed 
a characteristic pattern of variation in response to tRA. In 
Transfected 
CHO cells 
< X 
< X > ^ 
tRA Control 
Fig. 4. Effect of tRA on RARa and RXRa levels of control and pSV's 
transfected and treated with tRA 10~5 M as described in Section 2. 100 
most control cultures (not treated with tRA), the latter species 
was about 50% (± 7%, «=8) less abundant than the 58-kDa 
species, as judged from the relative intensities of the corre-
sponding bands; however, and for unknown reasons, some 
cultures showed a quite different pattern, with the low molec-
ular weight RARa species being the most abundant. 
Treatment of brown adipocytes in primary culture with 
tRA for a period of 48 h elicited characteristic dose-dependent 
changes in the steady-state levels of both RXRa and RARa 
(Fig. 2). Low tRA concentrations (10~9-10~7 M) slightly up-
regulated the receptor levels. At the highest tRA concentra-
tions tested (10~6 and 10~5 M), however, both RXRa and the 
low molecular weight RARa species were consistently down-
regulated ; down-regulation was especially marked for RXRa, 
with almost negligible levels at 10~5 M tRA. Certain down-
regulation of the 58-kDa RARa species at high tRA concen-
trations was also observed in some individual cultures, but not 
all (Fig. 2 and immunoblot therein). Fig. 3 shows the time-
course of the down-regulation of RXRa and RARa levels 
elicited by a single dose of tRA of 10~5 M added on day 5 
of culture. The effect was clear after 24 h, and persisted after 
48 h. 
The effect of tRA on RARs and RXRs levels is not re-
stricted to brown adipocytes. Thus, we have found that 
CHO cells express RARa (58 kDa) and RXRa (54 kDa), 
and that the levels of both receptors are lowered after tRA 
treatment, especially those of RXRa (Fig. 4). Treatment of 
confluent 3T3-L1 adipose cells with tRA 10~6 M for a period 
of 24 h was reported to cause a reduction of the RXRa 
mRNA levels [24]. Those are the kind of results to be expected 
if down-regulation reflects the existence of negative RA re-
sponse elements in the corresponding murine gene promoters. 
However, we have found that ectopic expression of RXRa 
driven by a constitutive heterologous promoter is reduced in 
CHO cells upon tRA treatment to an extent that cannot be 
explained by the mere reduction of the endogenous RXRa 
levels (Fig. 4), suggesting that down-regulation could as well 
be the result of a non-transcriptional regulatory mechanism. 
Clearly, further studies are needed to elucidate the mecha-
nism^) underlying the tRA-induced down-regulation of 
RXRa protein/mRNA levels in the different cell systems in 
which it has been reported (primary cultures of brown adipo-
cytes, CHO cells, 3T3-L1 cells). As pointed out by Kawada et 
al. [24], down-regulation of RXRa would have profound im-
plications in the cross-talk of the various signaling pathways 
Non- t ransfec ted 
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srtlhRXRa transiently transfected CHO Kl cells. Cells were cultured, 
tg of cell lysate protein was run per lane. 
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that use RXRa as a partner in heterodimer formation: lower 
levels of RXRa would imply competition between the various 
possible heterodimer partners for the RXRa available. 
In our previous report on the effect of RA on brown adi-
pocytes, maximal induction of UCP appearance was attained 
after treatment of primary cultures with tRA 10~6-10~4 M 
[9], and this result has been reproduced in the present experi-
ments (Fig. 2). Therefore, tRA apparently affects in opposite 
directions both the activity of pre-existing receptors as tran-
scription factors and the steady-state levels of those receptors. 
The fact that the same tRA concentrations that effectively 
induce UCP appearance, presumably through RAR/RXR het-
erodimers, down-regulate the steady-state levels of two likely 
heterodimer partners suggests an autoregulated system and 
thus reinforces the idea of a physiological role of RA in con-
trolling the thermogenic capacity of BAT. 
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